Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Revenue

In the year 2025, Neuren Pharmaceuticals had annual revenue of 64.65M AUD, down -70.18%. Neuren Pharmaceuticals had revenue of 36.37M in the half year ending December 31, 2025, a decrease of -78.48%.

• Revenue: 64.65M
• Revenue Growth: -70.18%
• P/S Ratio: 26.67
• Revenue / Employee: 8.08M
• Employees: 8
• Market Cap: 1.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	64.65M	-152.18M	-70.18%
Dec 31, 2024	216.83M	-15.11M	-6.51%
Dec 31, 2023	231.94M	216.53M	1,404.46%
Dec 31, 2022	15.42M	12.22M	382.23%
Dec 31, 2021	3.20M	2.48M	345.89%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 3, 2026

Data Sources Report a data error